Ares Management Corporation (NYSE: ARES) — The Run Was Survived, The Discount Wasn’t

Independent equity research. Report date: 2026-08-15. Price reference: $144.02 (2026-08-14 close). An update to my 14 June 2026 report on Ares.

⚡ Claude’s Take

This block is my own subjective opinion. It is general information and commentary, not investment advice, and is not a recommendation to buy or sell any security. Everything that follows this block is deliberately position-free and carries no recommendation and no price target — this opener is the single exception. Do your own work.

Verdict: HOLD — unchanged from June, but for the opposite reason. Then it was “good business, full price.” Now it is “good business that just proved something important, and got paid for it in six weeks.” Not a buy at $144.02. Fair-value zone ~$127–141; accumulate below ~$125; back up the truck only nearer ~$100–115. Conviction: medium.

Since the June report Ares did exactly what a franchise is supposed to do in a funding shock: it took a 14.4% redemption request at its $23 billion flagship non-traded BDC, satisfied the 5% cap without gating, selling assets into a bid-less market, or breaking a distribution, watched roughly 95% of accounts stay put, and halved the redemption queue from ~$1.2 billion to a little over $600 million in two quarters — while simultaneously raising a record $36 billion in a single quarter, deploying $36 billion against $27 billion a year earlier, and posting FRE +20% and realized income +31%. The prior memo’s bull falsification test (two-to-three quarters of sub-10% FRE growth, or non-accruals rising with broadening redemptions) was not hit; it was refuted. The embedded, already-contracted fee tailwind grew from $730 million to $828 million, now 24% of the trailing base-fee run-rate. That is the highest-quality quarter this business has printed under stress, and it deserves saying plainly.

So why not buy it? Because the stock rallied 33.8% off the 29 June low of $107.60 and now trades 6.8% above the June reference price on a franchise whose earnings are up about the same amount — the re-rating is arithmetically an earnings re-rating, not a discount. On its own ten-year history Ares sits at the 77th percentile of price-to-sales, identically to June, and at ~24x trailing FRE / ~22.5x FY26E — right where it was. Meanwhile three things got worse, and none of them are in the tape. First, Leonard Green: Ares has held preliminary talks to buy an $85 billion buyout firm, which would quadruple its private-equity assets into the one segment management itself calls episodic, at a moment when PE fundraising is slow and LPs are starved of DPI — funded, almost certainly, with the equity of a permanent net issuer that has never bought back a share. Second, nobody inside bought the panic: a director bought at $126.61 in February; at $107.60 in June, silence. Third, the factor tape did much of the work — Ares now loads +0.31 to CreditRisk and +0.46 to DividendYield, and those were the two best-performing style factors of the quarter (both z ≥ +1.0). The market has not re-underwritten Ares so much as it has re-embraced credit risk and yield. Framing: quality compounder, cyclically-timed rally, priced for the soft landing it is now more likely — but not certain — to get. Single piece of evidence that flips me bullish: the redemption queue reaching zero with U.S. direct-lending non-accruals still under 2%, and no large equity-funded private-equity acquisition — with the stock below ~$125. Single piece that flips me bearish: a signed Leonard Green deal at a full price paid in stock, which would swap a 94%-perpetual fee annuity for episodic carry and dilute the very thing the multiple is paying for. Tag: it passed the stress test, then charged you for the certificate.

🔄 Changes Since the 2026-06-14 Report

Nine weeks, one earnings print, one panic, one recovery, and one rumour. In order of thesis relevance:

What was confirmed. The core bull mechanics — locked capital, contracted embedded fees, fundraising leadership, diversified deployment — all strengthened. Perpetual/long-dated share of management fees rose from 93% to 94%. The prior memo’s Open Question #4 (“how quickly does deployment re-accelerate?”) is answered: it already has.

What was falsified. The bear’s near-term case that a retail funding shock would break the fee engine. It didn’t. The queue is shrinking, the caps held without gates or forced sales, and management expects the non-traded BDC to be larger at year-end 2026 than at year-end 2025.

What was not resolved, and what got worse. The FRE-margin question is still open — +100bps in a year of record scale, on a sector-low base, with the CFO candidly describing margin as something they will spend. The industry default rate is still a record 6.0% and flat. And the Leonard Green possibility introduces a genuinely new way for management to destroy value that did not exist nine weeks ago.

Does the call change? No — but its content does. In June the call was HOLD because the stock was expensive relative to a franchise facing an unproven stress. Today it is HOLD because the stress was largely survived and the stock has already collected the payment, while a new and larger capital-allocation risk has opened. Same verdict, different reason, slightly higher zone.

📈 Stock Price Action — Five-Year Event Map

Over five years Ares has round-tripped from ~$71 (August 2021) to an all-time high of $198.22 (31 January 2025) to a low of $96.50 (12 March 2026) and back to $144.02 — a -51% peak-to-trough drawdown followed by a +49% recovery. The stock sits -27.3% below its high, inside a 52-week range of $96.50–$189.27. Its ten-year record is +28.8% annualised with a -49.7% maximum drawdown: this is a high-return, high-amplitude vehicle, and the last eighteen months are characteristic, not anomalous.

Cycle narrative. (1) The 2021–22 decline was a rate-and-multiple event, not a fundamental one; fee revenue never fell. (2) The 2022–23 doubling is the capital cycle’s up-leg — bank retrenchment pushed middle-market lending to non-banks and Ares was the largest beneficiary. (3) 2024’s melt-up carried the stock to >9x price-to-sales, its richest-ever, on the GCP acquisition and index-inclusion flows; this is the overshoot everything since has corrected. (4) April 2025’s 40% air-pocket and complete recovery within four months is the cleanest demonstration of the stock’s beta: nothing about the business changed. (5) The August 2025 – March 2026 halving is the capital cycle’s bust-leg arriving in the retail funding channel, with Fitch’s U.S. private-credit default rate hitting a record 6.0% in April 2026. (6–7) The June 2026 second leg is the one the prior report did not see coming: from $135.36 on 15 June the stock fell nine sessions to $107.60 on 29 June, with the Reuters and Barron’s reports of the ASIF redemption cap (14.4% of shares requested) breaking mid-decline on 25 June and the Bank of England’s first private-markets stress test announced 22 June. (8) The recovery is bifurcated: the 31 July Q2 print added +3.2% on the day, but the larger single move was +8.2% on Monday 3 August as sell-side estimates were raised — and beneath both, the CreditRisk factor returned +5.8% and DividendYield +6.5% over the trailing quarter, the two factors Ares loads most heavily. Price moves are facts; the attributions above are interpretation.

1. Executive Summary

Ares Management is a global alternative asset manager — a capital-light toll road on private capital that raises long-dated third-party money, deploys it across credit, real assets, secondaries and private equity, and earns recurring management fees on assets under management plus a modest layer of performance income. At 30 June 2026 it managed $671.3 billion of AUM (+17.3% year on year), of which $409.9 billion was fee-paying (+17.2%), generating $1.02 billion of management fees in the quarter (+13%), $491.1 million of fee-related earnings (+20%) and $521.5 million of realized income (+31%). It remains the largest player in its core battleground, direct lending and private credit, where the Credit Group is 66% of AUM, and it externally manages Ares Capital Corp (ARCC), the largest publicly traded BDC.

This is an update, and the update is that the franchise passed a live stress test. Between March and June 2026 the private-credit wealth channel experienced a genuine funding shock: roughly $12.9 billion was withdrawn from wealth-oriented private-credit funds in the first five months of the year, and in the second quarter every major non-traded BDC — Apollo, Ares, Morgan Stanley, HPS, Cliffwater, Monroe and Blackstone — received redemption requests above their 5% quarterly cap. Ares’s flagship non-traded BDC saw 14.4% of shares submitted. It repurchased at the cap, did not gate, did not force-sell, did not cut distributions, and retained roughly 95% of accounts. The requests were concentrated: the top ten redeemers accounted for about half, they were predominantly non-U.S. family offices and smaller institutions representing ~10% of the vehicle’s NAV, and the regional queue halved from ~$1.2 billion to a little over $600 million across two quarters while core U.S. individual requests fell ~35% quarter on quarter to ~2.5% of NAV. Firm-wide, redemptions were $2.03 billion against a $671 billion AUM base — 0.30% of AUM, up from 0.20% a year ago, and swamped by $36 billion of gross inflows in the same quarter.

The operating results are, if anything, better than the pre-stress trend. Record quarterly fundraising of $36 billion (with roughly 70% of year-to-date capital raised outside the four largest credit fund families, across ~90 different vehicles); Pathfinder III closing first-and-final at its raised $8.5 billion hard cap against a $6.5 billion target; a record $170 billion of dry powder; investment activity of $36 billion versus $27 billion a year earlier; and a firmwide forward pipeline at a record, up ~20% sequentially, with signed NDAs up ~35%. Fee durability rose: 94% of management fees now come from perpetual capital or long-dated funds, and the already-contracted embedded fee tailwind grew to $828.2 million, a 24% increment on trailing base management fees, before any new fundraising.

Three things are less good. First, the FRE margin remains the group’s blemish: 42.3% year to date, up ~100 basis points, against full-year guidance of 0–150 basis points — and the CFO’s own framing is that margin expansion is something Ares will choose to reinvest into origination and distribution capacity. Operations Management Group costs grew 21% in the quarter against 13% management-fee growth. Second, corporate leverage is being pre-positioned: debt rose from $3.94 billion to $4.58 billion in six months, the revolver was upsized to $2.5 billion with a 2031 maturity, and $450 million of subordinated notes reset from 4.125% to 7.357%. Third, and most consequentially, Ares has held preliminary talks to acquire Leonard Green & Partners, an ~$85 billion buyout firm that would take its private-equity assets from ~$25 billion to over $100 billion — a step-change in strategy toward the segment management has itself characterised as episodic and non-linear.

At $144.02 the stock trades at ~24.3x trailing FRE per fully-exchanged share, ~27.9x trailing after-tax realized income per share, ~22.5x FY2026E FRE, 13.4x recurring management fees and a 3.75% forward dividend yield, and sits at the 77th percentile of its own ten-year price-to-sales range — identically to nine weeks ago, because earnings grew as fast as the price. Notably, the cohort has re-rated around it: on own-history percentiles Ares is now mid-pack, behind BAM (85th), APO (84th), KKR (74th), BX (72nd) and CG (71st), and well ahead of OWL (43rd) and TPG (40th).

This memo values Ares strictly on non-GAAP per-share metrics and a properly de-consolidated enterprise value; GAAP EPS, the screen-reported 45–82x “P/E”, the negative price-to-tangible-book and the $44.2 billion screen EV are artifacts of consolidated-fund and Up-C accounting and are discarded. The body takes no position and sets no price target; it lays out the embedded expectations, the scenario zones, and the falsification tests on both sides.

2. Business Overview

2.1 What Ares is and how it makes money

Ares Management Corporation, founded in 1997 and public since 2014, is a global alternative asset manager headquartered in Los Angeles, led by co-founder and CEO Michael Arougheti with co-founder Antony Ressler as Executive Chairman and a dual Co-President structure (R. Kipp deVeer and Blair Jacobson). It operates across North America, South America, Europe, Asia-Pacific and the Middle East. Critically for per-share analysis, Ares is a C-corporation issuing a Form 1099, not a K-1 — which broadens its investor base and avoids the structural complexity of legacy partnership alternatives.

The economic model is a fee machine. Ares raises capital into funds and vehicles, earns a recurring management fee on assets under management (the durable, annuity-like core), supplements it with fee-related performance revenues and performance income (carried interest and incentive fees — a minority of profit), and runs a small balance-sheet investment book. The business is capital-light: incremental AUM costs little incremental capital.

The quarter just reported is a textbook illustration of the model’s shape. Of $1.43 billion of GAAP revenue in Q2 2026, $1.02 billion was management fees; carried interest allocation of $250 million and incentive fees of $43 million are the volatile layer, and only $51 million of realized net performance income actually converted into distributable earnings. Fee-related earnings of $491.1 million were 94% of realized income of $521.5 million. Ares is a fee annuity with a carry option attached, not a carry P&L.

2.2 Segment structure (30 June 2026)

Two observations from the table matter to the thesis. First, growth is broadening away from Credit — Real Assets FRE grew 30%, Secondaries 21%, Insurance FPAUM 54%, versus Credit’s 17%. The prior memo’s central risk was concentration in one asset class at a bad moment in its cycle; the mix is diversifying in real time, and the Q2 deployment mix proves it (Mike Arougheti: “when you look at a slower Q1 in our U.S. Direct Lending business, we were still able to deploy $36 billion across the platform”). Second, the OMG cost line is the margin story. OMG expenses grew 21% in the quarter and 24% year to date against 13–17% fee growth. Headcount there rose 13% to 2,293 professionals. That is a deliberate build — distribution, capital solutions, technology — but it is the direct arithmetic reason a business with $671 billion of AUM still earns a 42% FRE margin.

2.3 The quality signatures, re-tested

Recurring fee dominance — improved. Management fees crossed $1 billion for a second consecutive quarter and grew 13% with no catch-up fees in the period. Part I fees (recurring, embedded in management fees) were ~$154 million, +20%, now generated across five different funds.

Fee durability — improved. 94% of Q2 2026 management fees came from perpetual capital or long-dated funds, up from 93% in FY2025; 84% of AUM sits in those vehicles. This is contractual, locked revenue, and it is the single most important number in the whole business. It is what allowed a 14.4% redemption request at one vehicle to be a headline rather than an earnings event.

The ARCC anchor. Ares Capital Corp remains the largest publicly traded BDC, externally managed at 1.50% of assets plus incentive fees, permanent exchange-listed capital and the firm’s twenty-one-year publicly auditable proof of concept. ARCC declared a $0.48 third-quarter dividend on 29 July 2026. Fees from ARCC rose $5.6 million in the quarter on FPAUM growth. The honest caveat carries forward from the prior memo: ARCC’s record was built largely in a fifteen-year era of falling-to-low rates and benign defaults, and the present cycle is its first real test at today’s scale — a test it is currently passing.

Three distribution channels — all working, at different speeds.

• Institutional (~75% of AUM) is the engine and is accelerating. It represented more than 80% of gross equity inflows over the trailing twelve months. Management’s field evidence for accelerating institutional private-credit demand is concrete rather than rhetorical: Pathfinder III raised $8.5 billion in a first and final close at a raised hard cap against a $6.5 billion target, which Arougheti said he could not recall Ares ever doing before, and the third opportunistic-credit vintage also hit its hard cap faster than its predecessor. The mechanism he offers is worth taking seriously as a hypothesis: institutions perceive an improved opportunity precisely because retail capital has withdrawn — “spreads have widened, less competition and therefore an ability to deploy maybe quicker and better returns.”
• Wealth ($76+ billion AUM) is growing through the shock. Gross equity commitments were $3.9 billion in Q2, up ~15% year on year and roughly in line with each of the prior two quarters; $8 billion in the first half; ~$1.5 billion in July alone. Wealth AUM grew at a >25% annualised sequential rate. Ares ranks #2 in Stanger gross fundraising over the trailing twelve months, and its Evergreen core-infrastructure product — not a credit product — has taken the lead in monthly inflows, raising $5.7 billion in just over two years for a #2 rank and ~20% share of infrastructure evergreen fundraising. That the wealth channel grew during the worst quarter of the retail private-credit shock is the strongest single fact in the update, and it is a direct vindication of the decision to build eight products rather than one.
• Insurance (AIS / Aspida) is the quiet compounder: FPAUM +54% year on year, the fastest line in the firm, with ~$2 billion of production across both the annuity and reinsurance channels in the quarter. The model remains deliberately asset-light — Ares manages insurance balance sheets rather than owning them, foregoing captured spread economics in exchange for carrying no spread or credit risk on its own balance sheet.

Verdict (Business Overview): A genuinely high-quality, recurring, capital-light fee model that has now demonstrated its durability under live funding stress, with the broadest product shelf in alternatives and the #1 franchise in its largest category. The mix is diversifying away from the single-asset-class concentration that was the prior memo’s central worry. Two qualifications persist: the FRE margin remains the lowest of the majors and is being deliberately reinvested rather than harvested; and the platform cost base is growing faster than fees, which is a choice management must eventually be held to.

3. Industry Dynamics

3.1 Structure

Alternative asset management is an oligopoly with a long tail: a handful of scaled global platforms (Blackstone, Apollo, KKR, Ares, Brookfield, Carlyle, Blue Owl, TPG) capturing a rising share of institutional and retail flows above thousands of sub-scale specialists. The structurally attractive feature is that customer capital is contractually locked for years or permanently, so revenue is far stickier than in traditional redeemable asset management — which is why alternatives command premium multiples to the traditional managers. The 2026 stress episode has, if anything, reinforced this: the vehicles that experienced runs were the semi-liquid retail ones, and even those were governed by contractual 5% quarterly caps that functioned exactly as designed.

3.2 The private-credit capital cycle — a stage further along

Because Credit is 66% of AUM, the Marathon capital-cycle lens on private credit remains the analytically decisive question. Since June the picture has advanced meaningfully, and it has bifurcated.

The funding shock has crested. In the first five months of 2026 roughly $12.9 billion was withdrawn from private-credit funds targeting wealthy individuals. In Q2 every major non-traded BDC — Apollo, Ares, Morgan Stanley, HPS, Cliffwater, Monroe, Blackstone — received requests above 5% and repurchased at the cap. But the direction of travel turned: Blue Owl’s OCIC requests fell to $3.6 billion from $4.2 billion; Ares’s regional queue halved over two quarters; core U.S. individual requests fell ~35% sequentially. Bank of America’s published view is that BDC redemption requests likely peaked in Q2 2026. Critically, the industry response was caps, not gates and not forced liquidation — a materially better outcome than the Blue Owl episode of early 2026, in which a fund was gated and ~$1.4 billion of loans force-sold.

The asset-side default cycle has not resolved. Fitch’s U.S. private-credit default rate reached a record 6.0% in April 2026 and remained at 6.0% in May — flat at a record, not falling. Private-credit-backed corporate borrowers defaulted at 9.2% in 2025. But the distribution is the story: sub-$25 million EBITDA borrowers defaulted at 15.8% in 2025 against 4.0% for borrowers above $100 million EBITDA. The default cycle is real and is concentrated in the small end of the market — the segment scaled lenders like Ares structurally do not serve. This is the single most important reconciliation in the industry read: a 6.0% headline industry default rate and Ares’s sub-2% direct-lending non-accruals are not contradictory data points, they are the same data point viewed at different points on the borrower-size curve.

The genuinely worrying industry datum is deployment, not defaults. Reuters reported on 9 July 2026 that U.S. direct-lending activity fell sharply in Q2 even as fundraising rebounded — capital is accumulating faster than the deal flow to absorb it. That is the classic Marathon precondition for the next round of spread compression and covenant erosion, and it is the mechanism by which today’s record $170 billion of Ares dry powder becomes tomorrow’s mediocre vintage if the M&A recovery does not arrive. Management’s counter-evidence is specific and testable: a firmwide pipeline at a record, up ~20% sequentially; signed NDAs up ~35% and logged deals up ~30% quarter on quarter; 75% of U.S. direct-lending deployment sourced from incumbent borrowers rather than new sponsor M&A. Treat the pipeline as a hypothesis with a two-quarter falsification window.

Regulatory attention has escalated. On 22 June 2026 the Bank of England launched its first private-markets stress test, with Apollo, Ares, Blackstone, KKR and JPMorgan participating. This is a two-sided development: it raises the probability of eventual capital, liquidity or disclosure requirements on private-credit vehicles, and it simultaneously entrenches the scaled incumbents who can absorb the compliance burden. The prior memo’s regulatory net-tailwind read (bank disintermediation, 401(k)/retail access under Executive Order 14330 and the March 2026 DOL/EBSA proposed safe harbour, insurance outsourcing) survives, but the near-term retail-protection overhang is now heavier, and the 2026 redemption episode is exactly the evidence a regulator would cite against loosening defined-contribution access on the “timely and accurate valuation” condition.

3.3 Secular demand — the structural case is intact

The post-GFC regulatory arbitrage that created private credit — Basel III and successors making it expensive for deposit-funded banks to hold middle-market and leveraged loans — has not reversed. Borrower demand relocated to non-bank vehicles funded by long-dated institutional and insurance capital, and that relocation is durable for as long as the rules stand. The nuance carried forward from the prior memo is exactly right and is being confirmed in real time: the demand for private credit is structurally supported (it is taking share from banks, not inflating aggregate leverage), while the supply of capital chasing it has overshot. Both are true; the secular winner can still suffer a cyclical funding-and-loss episode. What 2026 has added is evidence about which capital was excess: it was the retail semi-liquid capital, not the institutional locked capital. The institutional side of the market is currently increasing its appetite because the retail side withdrew.

Four additional demand legs are unchanged and one has strengthened. Insurance general-account outsourcing continues (Ares insurance FPAUM +54%). Wealth under-allocation remains, with individual allocations to private markets still in the low single digits. The retirement/401(k) opening remains a large but delayed option. And the data-centre and power build-out has strengthened materially: Ares’s Ada Infrastructure platform now employs over 100 professionals executing seven large campuses comprising 22 individual data-centre investments with approximately 1 gigawatt of compute, and a seed portfolio offering investors ~700 megawatts of identified development opportunity. Management reaffirmed a forecast of $50–100 million of FRE from digital infrastructure in 2027 and beyond.

3.4 Competitive intensity

Competition for capital continues to concentrate toward scale leaders — Ares’s record fundraising quarter, achieved with roughly 70% of year-to-date capital raised outside its four largest credit fund families, is the direct evidence. Competition for assets remains the pressure point, and management’s own Q2 disclosure is honest about a related margin drag: the Credit Group’s effective management fee rate declined, “primarily attributable to increases in FPAUM from funds in our liquid credit strategy, which have an effective fee rate of less than 0.50%.” Growth is coming partly from lower-fee product. That is a real, quantified mix headwind that partially offsets the operating leverage story.

Verdict (Industry Dynamics): STRUCTURALLY GOOD industry for scaled incumbents; the cyclical cloud has thinned on the funding side and persists on the asset side. The retail run appears to have crested with contractual caps functioning as designed rather than gates or fire sales, and institutional demand is accelerating in response to the retail withdrawal — a genuinely favourable configuration for the capital-rich survivor. But the record industry default rate has not fallen, deployment is lagging fundraising across the industry, and regulators are now formally stress-testing the asset class. The industry is good; the entry point in the cycle is better than it was in June but not yet demonstrably safe.

4. Competitive Position

4.1 The moat, named in the Greenwald taxonomy

Ares’s advantage remains a combination of economies of scale plus customer captivity (the strongest and most durable Greenwald type), intangibles (track record, brand, fundraising flywheel) and switching costs embedded in locked, long-dated capital. Nothing in the update weakens this; two things strengthen it.

Economies of scale plus captivity. Direct lending and asset-based finance exhibit genuine scale economics: a larger origination platform sees more deals, can lead and control terms, can write very large tickets, and can offer certainty of capital that sponsors pay for. The flywheel is self-reinforcing — scale produces selection and incumbency, which produce lower loss rates, which produce track record, which produces fundraising, which produces scale. The captivity is the locked capital: 94% of fees from vehicles that cannot walk away annually.

The 2026 stress episode is the cleanest moat evidence Ares has ever produced. The Greenwald test for a moat is whether a financial outcome would deteriorate in its absence. Here the test ran live. A 14.4% redemption request arrived at a $23 billion vehicle; because 94% of the fee base sits elsewhere in locked structures, the firm-wide consequence was 0.30% of AUM leaving in the quarter against 5.4% arriving. A sub-scale competitor with the same request would have gated, sold assets into a poor bid, and impaired its track record permanently. Ares repurchased at the cap and kept raising records. The moat converted a potential solvency-of-franchise event into a line item. That is the mechanism working.

Scale as a counter-cyclical weapon. Arougheti’s account of the direct-lending market is the capital-cycle survivor dynamic stated plainly: Ares’s team “leaned in pretty heavily to incumbent relationships,” was “more selective than they have been in quite some time” with “a lower closing rate this quarter relative to historical averages,” and did so because “our competitive advantage is improving as some of the retail-heavy competitors are not forming capital to the same extent that we are.” Being able to raise a record $36 billion while competitors face redemptions is a durable advantage that only shows up in a downturn — which is exactly when it is worth the most.

4.2 Comparison versus peers

Own-history percentiles are AZI valuation_index composites as of 2026-08-14 and compare each company only against its own multi-year range — they are not cross-sectional cheapness measures. AUM figures are latest-disclosed and approximate for peers.

Read, and a correction to the prior memo’s framing. In June the prior report concluded that Ares carried “the richest multiple in the peer group.” On absolute fee-earnings multiples that was and probably still is directionally true — though that comparison was struck on June prices and FY2025 peer disclosures and has not been rebuilt from fresh peer filings this run, so it should be treated as vintage context. On the fresh evidence — own-history percentiles as of 14 August — Ares is no longer the standout: the entire cohort re-rated with the credit-risk factor, and BAM, APO, KKR, BX and CG all now sit at higher percentiles of their own histories than Ares does. Blue Owl at the 43rd percentile and Hamilton Lane at the 28th remain the genuinely contrarian names. Versus Blue Owl specifically — the closest factor comparable at 0.959 similarity — Ares is more than twice the size, far more diversified across five investment groups, and came through the same redemption wave without gating or force-selling. That difference in outcome, at the same moment in the same cycle, is itself competitive-position evidence.

4.3 Pressure-test

• Network effects: weak to none in the strict sense. The “more sponsors, more deals” dynamic is scale plus incumbency, not a two-sided network. Reject.
• Switching costs: real but moderate. Locked capital is contractual rather than preference-based; limited partners can decline the next vintage. The stickiness is structural, and the 2026 episode showed the structure holds — but it also showed the semi-liquid retail perimeter is the soft edge, and management is now explicitly hardening it (“lockups and redemption penalties and regional redemption queues” on new share classes).
• The genuine, durable edge is scale-driven origination plus a twenty-year loss record plus a locked fee base. Without it, loss rates rise and fundraising slows — measurable outcomes, both of which were tested in 2026 and neither of which deteriorated.
• The counter-argument that survives: the moat still does not show up in margin. At $671 billion of AUM and twenty-nine years of operation, a 42.3% FRE margin is the lowest of the majors. The bull reading is that margin is depressed by deliberate growth investment; the bear reading is that a people-intensive, self-origination credit model simply does not operate-lever like an allocator model. The Q2 evidence is genuinely ambiguous and slightly favours the bull — margin up ~100 basis points, GCP transition service agreements exited, the data-centre platform turning FRE-accretive in 2027 — but the CFO’s own words are the most important datum: “even when we have margin expansion, we’re constantly looking at the team — are there areas where we can be investing to create more business.” Margin at Ares is a policy variable, not a structural constant. Investors should price it as such.

Verdict (Competitive Position): DURABLE ADVANTAGE, and better evidenced than it was nine weeks ago. The 2026 funding shock ran the moat test in public and the moat held: locked capital absorbed a 14.4% single-vehicle redemption request as a 0.30%-of-AUM firm-wide event, while the scale advantage let Ares raise records into competitors’ distress. The unresolved qualification is unchanged and is a matter of degree rather than kind: the advantage shows up in growth and durability rather than in margin, which caps how high a multiple the franchise can rationally command relative to KKR or Blackstone.

5. Growth History and Forward Opportunities

5.1 The compounding record, updated

Five-year compounding across every operating line remains in the high teens to mid-twenties. The important point about the TTM column is when it was earned: the trailing twelve months contain the worst quarters of the private-credit funding shock, and the growth rates through them are at or above the long-term algorithm. Management reaffirmed its 2024 Investor Day targets — 16–20% FRE CAGR, 20%+ RI CAGR, and ~20% dividend growth — and noted that Q2’s 20% FRE and 31% RI growth sat “at the high end or above” those ranges.

5.2 Organic versus acquired

Growth is genuinely mixed but organically led. The GCP International acquisition (closed 1 March 2025) contributed $30.8 million of the six-month increase in Real Assets management fees, largely from two extra months of ownership in the comparative period — a comparability artifact that washes out from Q2 2026 onward. The BlueCove acquisition (closed 1 February 2026) contributed $5.6 million of the quarter’s Credit fee increase. Set against $86.3 million of total Credit fee growth in the quarter, of which $39.4 million came from capital deployment in SDL III, ACE VI, the open-ended core alternative credit fund, ASOF III and Pathfinder II, and $42.8 million from perpetual wealth vehicles, the overwhelming majority of fee growth is organic deployment and fundraising. Acquisitions supply capability and adjacency, not the growth rate.

5.3 The forward book — where the next dollar of fees comes from

The contracted layer (the strongest thing in the business). At 30 June 2026 Ares carried $114 billion of AUM not yet paying fees, of which $92.6 billion is available for future deployment and $4.1 billion is development assets not yet stabilised, collectively capable of generating ~$828.2 million of incremental annual management fees — a 24% increment on the trailing base-fee run-rate. This is not a forecast; it is committed capital under existing contracts awaiting deployment. It grew from $730 million / 23% in the prior report. Add a record $170 billion of available capital and the medium-term fee trajectory is far more contractual than most equity growth stories.

The institutional pipeline. The next generation of the U.S. senior direct-lending strategy has both a traditional commingled fund and a new Evergreen core product in market, with first closes expected in the autumn and further closings in 2027. The seventh European direct-lending fund launches early 2027 — and European direct lending is described as the current bright spot, more fragmented than the U.S. with fewer scaled lenders and a greater premium on local origination. Infrastructure debt fund six has raised ~$3.7 billion of a raise expected to close above the prior vintage’s $5 billion. The fifth Japan industrial development fund raised $1.8 billion in the quarter toward ~$3.4 billion and expects a final close at hard cap meaningfully above the prior $2.5 billion vintage. A new global real-estate-debt commingled fund and separate accounts raised $2.8 billion. The next real-estate secondaries fund holds an initial close in the second half, running ahead of the prior vintage’s pace.

Digital infrastructure — the highest-torque new leg. The global digital-infrastructure fund is expected to hold a series of meaningful closings in late Q3 and Q4 2026 with completion in 2027. The differentiator is vertical integration: Ada’s ~100 professionals cover investing, development, engineering, construction and power procurement, and Ares charges the cost of that team back to the fund — which, as Blair Jacobson explained, produces better investor returns and better economics to Ares than the outsourced peer model. Reaffirmed contribution: $50–100 million of FRE in 2027 and beyond. Against a ~$2.1 billion FY2026E FRE base that is a 2–5% increment — meaningful, not transformative, and worth watching as a discrete falsifiable milestone.

Wealth product extension. The forward work is interval-fund structures aimed at the mass-affluent and model-portfolio markets, plus “building blocks” recombining the existing eight products into geography- and outcome-specific wrappers. Arougheti’s read on liquidity terms is notable and, on the Q2 evidence, defensible: “the individual investor is buying the product with the 5% quarterly liquidity and seems very happy with it.” Nearly 200 professionals now focus on the channel.

Secondaries. Credit-secondaries industry volumes through the first six months of 2026 have already matched full-year 2025 — a genuine structural acceleration driven by LPs seeking liquidity and GPs seeking DPI. Ares’s global structured-solutions strategy raised over $500 million in the quarter and APMF is now the firm’s principal fee-related-performance engine.

5.4 Growth quality

The quality signature is strong: growth is broadly sourced (~90 vehicles took commitments year to date, ~70% of capital outside the four largest credit fund families), contractually underpinned ($828 million embedded), and increasingly diversified by asset class (Real Assets FRE +30%, Secondaries +21%, Insurance FPAUM +54% versus Credit’s +17%). The one genuine blemish is fee-rate mix: growth in liquid credit at sub-0.50% effective rates is diluting the blended fee rate, so AUM growth of 17% translated to management-fee growth of only 13% in the quarter. Volume is outrunning price.

Verdict (Growth): HIGH-QUALITY GROWTH — and the highest-quality evidence of growth quality the firm has produced, because it was generated through a live funding shock. Record fundraising, a record pipeline, record dry powder and a 24% contracted embedded fee tailwind make the mid-to-high-teens FRE trajectory closer to a contractual obligation than a forecast. The deduction is the fee-rate mix drag, which means AUM growth systematically overstates revenue growth by roughly four percentage points.

6. Financial Quality

6.1 The income statement that matters

GAAP is nearly useless here and must be set aside deliberately. Q2 2026 GAAP net income attributable to Ares Management Corporation was $150.6 million, or $0.49 per share, on total revenues of $1.43 billion — because consolidation of Ares funds grosses up assets, liabilities and cash flows, then strips most of the economics out again through non-controlling interests, and because unrealized carried-interest swings pass through revenue. On the relevant basis:

The composition is high quality: FRE was 94% of RI, meaning virtually all distributable earnings came from recurring fees rather than lumpy carry. Realized net performance income tripled but remains a rounding layer, and management guided Q3 realized net performance income to only ~$10 million — a disclosed, mechanical air-pocket that will make Q3’s RI growth look materially weaker than Q2’s without any change in the business.

6.2 Margin — the one unresolved question, examined honestly

The FRE margin is the analytical crux, so it deserves the arithmetic rather than the assertion.

Year-to-date FRE margin is 42.3%, roughly 100 basis points above the prior-year period, against full-year guidance of 0–150 basis points of improvement, with management stating it expects to approach the upper end. Independent reconstruction from the segment tables — FRE divided by the sum of management fees, fee-related performance revenues and other fees — gives ~42% for Q2 2026 against ~41.8% for Q2 2025, consistent with management’s calculation.

Three things are pushing margin up and three are pushing it down.

Up: (i) the GCP transition service agreement with the “left-behind” vehicle has been exited and the acquired operations are now fully integrated, removing duplicated fixed cost; (ii) the biennial firmwide annual general meeting for institutional LPs put ~$9 million of expense into Q2 2026 that will not repeat in Q3 or Q4, mechanically improving second-half margin; (iii) the digital-infrastructure platform, currently FRE-dilutive, is guided to contribute $50–100 million of FRE from 2027.

Down: (i) OMG expenses grew 21% in the quarter and 24% year to date against 13–17% fee growth, with headcount there up 13% to 2,293 — the platform build is outrunning the revenue it supports; (ii) the Credit Group’s effective management fee rate fell on liquid-credit mix at sub-0.50% rates; (iii) management has stated it will reinvest margin gains rather than bank them.

That third point is the one investors should internalise. Asked directly about the margin trajectory, the CFO’s answer was candid to the point of being a warning: “our primary goal is growth… even when we have margin expansion, we’re constantly looking at the team — are there areas where we can be investing to create more business. And once we have that margin expansion, that’s a one-time expansion of FRE, as sustainable as just the organic growth of creating more revenue.” Translated: Ares views 100 basis points of margin as fungible with growth investment, and will spend it when the return looks good. Anyone underwriting a march from 42% to a peer-like 55%+ is underwriting a change in management philosophy, not an operating-leverage mechanic.

6.3 Balance sheet and leverage

The balance sheet remains capital-light and, at the corporate level, conservative — but it moved this half.

Separately, $6,952 million of CLO loan obligations and $2,531 million of fund borrowings sit on the consolidated balance sheet but are non-recourse to Ares — which is precisely why screen enterprise values (ROIC.ai reports $44.2 billion) are unusable: they add roughly $9.5 billion of fund debt and $4.6 billion of non-controlling interests that Ares neither owes nor owns.

Three specific items deserve flagging. First, corporate debt rose 16% in six months while the revolver was upsized from $1.84 billion to $2.50 billion (accordion to $3.0 billion) with maturity extended to May 2031 — a capacity build that looks like preparation for a use of funds. Second, the $450 million of subordinated notes due 2051 reset from 4.125% to 7.357% on 30 June 2026, adding roughly $14.5 million of annual interest cost — a small but permanent drag that recurs on a five-year reset cycle. Third, at 2.34x TTM FRE, corporate leverage remains comfortably investment-grade for a fee business; this is a change in degree, not in character.

6.4 Quality of earnings

The non-GAAP measures Ares reports are the industry standard and are the right basis for valuing the business, but they are not neutral. Equity compensation expense of $182.8 million in the quarter and $386.4 million year to date is added back to reach RI — a real economic cost borne by shareholders through the 1.0% share-count growth of the last two quarters. Acquisition-related compensation of $28.2 million in the quarter is likewise added back. Any investor using FRE or RI as a proxy for owner earnings should subtract at least the cash-equivalent portion of stock compensation, which on the year-to-date run-rate is a mid-teens percentage of FRE. This is the single largest QoE caveat in the business and it is unchanged from the prior report.

Two smaller items. The $37.3 million bargain purchase gain on BlueCove flows through GAAP other income and must be normalised out of any GAAP earnings read — though it is a favourable signal about the price paid. And the placement-fee adjustment, other income, and unrealized performance swings between GAAP and RI are large enough that the reconciliation table, not the income statement, is the document to read.

Cash conversion is healthy. One-half-year GAAP dividends declared and paid on common were $610.8 million against $955.5 million of FRE and $1,024.2 million of RI — a payout comfortably funded from recurring fee earnings rather than carry, which is the central design feature of the dividend policy.

Verdict (Financial Quality): STRONG, with a single unresolved question. Revenue quality is excellent (94% of fees perpetual/long-dated, 94% of RI from FRE), growth is high-teens-to-thirties across every line, cash conversion funds the dividend from fees rather than carry, and the corporate balance sheet is capital-light and investment-grade at 2.3x FRE. Economics do improve with scale — but slowly, and by management’s own account partially by choice: a 42.3% FRE margin at $671 billion of AUM, improving ~100 basis points a year against a peer group in the mid-50s to high-60s, is the one place where this business is demonstrably second-tier.

7. Capital Allocation

7.1 The record, and the new question hanging over it

Capital allocation has been above average for the sector and is the reason the prior memo’s verdict was positive. The M&A framework management articulates — culturally accretive, strategically accretive, capable of being made better by Ares, financially accretive — has a genuine track record: Landmark (2021), which doubled and became the secondaries franchise; Black Creek (2021), which became the engine of the wealth business; AMP infrastructure debt (2022); Crescent Point (2024); GCP International (2025); and now BlueCove (February 2026).

The GCP mark-to-market is genuinely good. Management describes progress on all three legs of the original thesis: the Japan institutional development franchise is in market with a vintage expected at hard cap and meaningfully larger than the $2.5 billion predecessor; the global logistics platform has been consolidated under the Marq Logistics brand with revenue and expense synergies realised; and the digital-infrastructure platform is executing seven campuses with ~1 gigawatt of compute. Management now expects the GCP earn-out to be paid — and made an important structural point: because the earn-outs are milestone-based on fundraising, management fees and FRE, “when they get paid, it effectively is reflected as buying down our multiple.” That is correct and is a genuinely good deal-structuring practice.

BlueCove is a smaller but revealing datum: Ares acquired the remaining 85% of a London systematic fixed-income manager and recorded a $37.3 million bargain purchase gain, meaning it paid less than the fair value of the identifiable net assets acquired. Buying assets below appraised value is the opposite of the overpayment risk that dogs serial acquirers.

And then there is Leonard Green. On 28 July 2026, the Financial Times reported that Ares has held preliminary talks to acquire Leonard Green & Partners, a Los Angeles buyout firm managing approximately $85 billion. A transaction would take Ares’s private-equity assets from roughly $25 billion to over $100 billion — more than quadrupling the buyout platform and making it, by AUM, roughly 3.4 times the size of the GCP deal, the largest acquisition in the firm’s history by a wide margin. Talks are preliminary and may not lead to an agreement; no price, structure or funding mix is public.

On the call three days later, Alex Blostein asked directly. Arougheti declined to comment on rumours but did not disclaim the strategic direction — quite the opposite. Asked whether Ares should be bigger in private equity, he said “I think the answer is probably,” and laid out four arguments: LP relationship consolidation means institutional clients committed to private equity would like to do more of it with Ares; a larger PE presence broadens the solutions Ares can offer companies and entrepreneurs; it deepens capital-markets and financing wallet; and it feeds wealth-channel demand for direct private-equity exposure. He then added the crucial caveat: “the price has to be right because the growth profile of these businesses is less linear and more episodic than some of the core businesses.”

7.2 Why this is the largest single risk to the thesis

The market pays Ares roughly 24x fee-related earnings because those earnings are a 94%-perpetual, contractually locked, recurring annuity. Private-equity economics are the opposite: closed-end vintages with finite lives, episodic carry realisation, and — right now — an industry-wide fundraising slowdown and a backlog of ageing portfolio companies awaiting exits. Management itself has previously described Ares’s PE business as “not a growth business.” Buying $85 billion of it would:

1. Dilute the mix that earns the multiple. Moving from ~4% to ~15% of AUM in closed-end private equity shifts the revenue mix away from the perpetual/long-dated share that is the single best quality attribute in the business.
2. Almost certainly be funded with equity. Ares is a permanent net issuer with no buyback history; fully-exchanged shares grew 1.0% in two quarters, and the corporate balance sheet at 2.34x FRE has capacity for perhaps $1–2 billion of incremental debt before straining its ratings, not for a transaction of this scale. The revolver was just upsized to $2.5 billion with a 2031 maturity and a $400 million term loan added — capacity being built ahead of a use.
3. Be priced into a weak seller’s market — or not. Slow PE fundraising cuts both ways: it should make a target cheaper, but sellers of $85 billion franchises rarely accept trough valuations, and the strategic logic Arougheti describes is exactly the kind of logic that justifies paying up.
4. Consume management attention at the moment the wealth channel is being re-architected and the digital-infrastructure platform is scaling.

The counter-case is real and should not be dismissed. Ares has integrated four platforms well in five years; the earn-out structure it favours genuinely buys down the multiple; the industrial logic on LP consolidation is sound; and Blue Owl, Apollo and KKR have all built adjacent capability inorganically. But the base case for this memo is that no deal is signed, and the risk is priced as an open, two-sided variable rather than as a forecast.

7.3 Dividend, dilution and buybacks

The quarterly dividend was held at $1.35 per share for the third consecutive quarter (declared 31 July, payable 30 September 2026), still +20% versus the year-ago quarter; the annual step-up has historically come with the Q4 print. Forward run-rate $5.40, a 3.75% yield at $144.02. The policy anchors distributions to after-tax FRE rather than GAAP, which is why a payout of $610.8 million in the first half against $955.5 million of FRE is comfortably covered. Management reaffirmed ~20% dividend growth as a long-term target.

A Dividend Reinvestment Program becomes effective with the September 2026 dividend. It is a mild, ongoing new source of share issuance — small, but directionally consistent with Ares’s character as a permanent net issuer.

On dilution: fully-exchanged shares rose from ~327.1 million to 330.28 million in two quarters, +1.0%. Equity compensation of $386.4 million year to date is the driver. The $1.46 billion Series B mandatory convertible preferred converts on 1 October 2027, adding roughly 30 million shares to the count. Ares has never repurchased shares. For a business generating $1.95 billion of TTM FRE with a 3.75% yield and no buyback, the capital-return policy is entirely dividend-and-reinvest. That is defensible while the reinvestment opportunity set is this rich; it becomes indefensible if a large acquisition is funded with stock at a price management would not otherwise pay.

7.4 Incentive alignment

Unchanged and strong. The founders take no salary or cash bonus, paid instead through carried interest and equity, which aligns them with fund limited partners; co-founder Ressler’s stake is approximately 19.7% fully exchanged; carry vests over five years with clawback; say-on-pay support was 92.3%. The governance trade-off is founder-controlled voting.

The one new negative is insider behaviour. Between 1 June and 3 August 2026 the Form 4 record shows: six non-employee directors each receiving 1,728 shares as the routine annual retainer (code A, $0); the CFO having 2,583 shares withheld for taxes at $113.63; the CEO and Co-President deVeer each having 82,957 shares withheld for taxes at $111.31 on a vesting event; and Co-President Jacobson making an 8,000-share gift. There was no open-market purchase by any insider — including on 29 June, when the stock closed at $107.60. A director bought 10,000 shares at $126.61 on 6 February. Nobody repeated that trade nearly 15% lower four months later. This is not evidence of anything wrong; officers face blackout windows and concentration constraints. But the prior report cited the February purchase as part of its alignment case, and honesty requires noting that the signal was not repeated at a better price.

Verdict (Capital Allocation): ABOVE-AVERAGE, on watch. The deal record is genuinely good, the earn-out structures buy down multiples, the dividend is conservatively anchored to fee earnings, and founder alignment is among the best in the sector. But the profile has shifted from “disciplined serial bolt-on acquirer” to “potential transformational acquirer with a freshly upsized revolver, no buyback, and a permanent-net-issuer share count” — and the acquisition contemplated is into the lowest-quality segment of the business. The verdict stays positive because nothing has actually been done; it would flip on a large, equity-funded deal at a full price.

8. Changes and Headwinds — Last Two Years

2024 — the euphoria. Record fundraising, AUM through $460 billion, the stock reaching $183.70 in December, and the announcement of GCP International. Price-to-sales exceeded 9x, the richest in the company’s history. This is the overshoot everything since has been correcting.

March 2025 — GCP International closes. Approximately $3.9 billion initial consideration (up to ~$5.6 billion with earn-outs) for GLP Capital Partners ex-China. Transformational for Real Assets: near-doubling of the segment, a top-three global industrial real estate position, a Japan institutional and J-REIT franchise, and the Ada digital-infrastructure platform. Segment reporting was realigned in Q1 2025 (real estate and infrastructure combined into Real Assets, interest-expense allocation changed), which impairs segment comparability across the boundary.

April 2025 — the tariff air-pocket. The stock fell to $118.04, -40% from the January high, on macro rather than company news, then fully recovered to $192.76 by August. Nothing about the business changed.

December 2025 — S&P 500 inclusion. Index flows and a broadened institutional shareholder base.

Late 2025 through Q1 2026 — the private-credit redemption crisis. The defining event of the period. Blue Owl gated a non-traded BDC and force-sold ~$1.4 billion of loans; BDCs traded at 27–34% NAV discounts; Fitch’s U.S. private-credit default rate reached a record 6.0% in April 2026. Ares fell in sympathy to $96.50 on 12 March 2026, -51% from its August 2025 high, with single-day declines of -10.2% (3 February) and -11.2% (5 February, the Q4’25 print).

February 2026 — BlueCove. Acquisition of the remaining 85% of a London systematic fixed-income manager, recorded with a $37.3 million bargain purchase gain. Small, capability-additive, well-priced.

May 2026 — revolver upsize. Amendment No. 14 raised commitments from $1.84 billion to $2.50 billion (accordion to $3.0 billion) and extended maturity to May 2031.

June 2026 — the second redemption leg. The stock fell 20.5% in nine sessions from $135.36 to $107.60. Reuters and Barron’s reported on 25 June that Ares had again capped withdrawals at its ~$23 billion flagship non-traded BDC after 14.4% of shares were submitted for redemption. On 22 June the Bank of England launched its first private-markets stress test with Ares among five participants. On 18 June Brent Canada was appointed Head of Infrastructure Debt, succeeding Patrick Trears. On 10 June Pathfinder III closed at $8.5 billion — first and final, at a raised hard cap, against a $6.5 billion target.

July 2026 — Whitestone and Leonard Green. On 14 July, Ares Real Estate funds completed the acquisition of Whitestone REIT for $19.00 per share, ~$1.7 billion all-cash, adding 54 properties. This is fund-level capital that generates fees for Ares, not a corporate acquisition, and must not be read as one. On 28 July the FT reported preliminary talks to acquire Leonard Green & Partners (~$85 billion AUM).

31 July 2026 — the Q2 print. Record $36 billion quarterly fundraising, FRE +20%, RI +31%, after-tax RI per share $1.29 (+25%), AUM $671.3 billion, record $170 billion dry powder, embedded fee tailwind to $828 million. The stock rose 3.2% on the day and a further 8.2% on 3 August as sell-side estimates were raised.

Verdict (Changes): NET STRENGTHENING, with one new open risk. The two years contain a transformational and so-far-successful acquisition, an index inclusion, a well-priced capability bolt-on, a materially improved credit facility, and — decisively — a live funding-stress test that the franchise passed while setting fundraising and deployment records. Against that: the equity has round-tripped violently, the industry default rate sits at a record, disclosure precision on non-accruals has loosened, and a potential transformational acquisition into the weakest segment has appeared on the horizon.

9. Risk Analysis

The shape of the risk. Nothing in this matrix is existential. The realistic bad outcome is cyclical and valuation-driven: a genuine broadening of the default cycle compressing growth and multiple simultaneously in a stock with a 1.566 beta and a demonstrated -49.7% maximum drawdown. What is new since June is that risk #1 did not exist nine weeks ago and now ranks first, while risk #5, the prior report’s central worry, has demonstrably improved — the redemption wave was survived, quantified, and appears to have crested. That is a favourable rotation of the risk profile in aggregate, but it moves the biggest remaining uncertainty from something the market can observe (redemption queues, published weekly) to something it cannot (a private negotiation).

10. Valuation Discussion (Embedded Expectations)

10.1 The clean per-share build

Valuation must use non-GAAP per-share metrics on the fully-exchanged share count and a de-consolidated enterprise value. Screen metrics are artifacts: ROIC.ai reports a FY2025 P/E of 82.4x, a price-to-tangible-book of -13.0x and a Q2’26 enterprise value of $44.2 billion on a $25.1 billion market cap — the EV wrongly adds ~$9.5 billion of non-recourse CLO and fund debt plus ~$4.6 billion of non-controlling interests, and the market cap counts only Class A shares. All are discarded.

Note on denominators: the company reports after-tax RI per share on a fully diluted basis implying ~362.5M shares (inclusive of the preferred as-converted); FRE per share above uses the 330.28M fully-exchanged count. Both are labelled wherever used.

10.2 Multiples at $144.02 (2026-08-14)

The headline is that the multiple barely moved. The stock is 6.8% higher and trailing fee earnings are ~7% higher; the valuation is where it was. This is the single most important valuation fact in the update: the July–August rally was an earnings re-rating, not a multiple re-rating. The corroborating evidence is that Ares’s own-history price-to-sales percentile is 77.1 today and was 77.1 on 12 June — identical, because sales grew as fast as the price.

10.3 Own-history and peer context

On its own ten-year history Ares sits at the 68.7th percentile of the AZI composite valuation index (up from 66.3), with P/S at the 77.1st percentile (unchanged), P/B at the 72.4th (up from 60.7, because distributions in excess of GAAP earnings shrink book value relative to price) and P/E at the 56.6th (a GAAP-distorted metric that should be discounted; P/S is the cleanest own-history gauge for this business). ROIC’s own-history price-to-sales series frames it: FY2025 6.27x, FY2024 9.03x (the euphoria peak), FY2023 6.04x, FY2022 3.93x, FY2021 3.16x, FY2019 2.18x. The current 5.26x is above the ten-year median and well below the 2024 peak.

The peer picture has changed, and this corrects the prior memo’s framing. In June, Ares was characterised as carrying the richest multiple in the group. On fresh own-history percentiles as of 14 August, it does not: BAM 85.1, APO 84.2, KKR 74.1, BX 71.7, CG 70.5, ARES 68.7, OWL 43.0, TPG 40.2, HLNE 27.6. The whole cohort re-rated together with the credit-risk and dividend-yield factors, and Ares is now mid-pack. Blue Owl (43rd percentile) and Hamilton Lane (28th) remain the contrarian end of the sector. The absolute fee-earnings-multiple comparison in the prior report — Ares ~25x versus KKR and Apollo around 15–16x and Blue Owl around 12x — was struck on June prices and FY2025 peer disclosures, has not been rebuilt from fresh peer filings this run, and should be treated as vintage directional context only.

10.4 Forward estimates

Built on management’s reaffirmed algorithm (16–20% FRE CAGR, 20%+ RI CAGR), the 1H’26 actuals, and ~1.5–2% annual dilution. These are assumptions, not facts, and not consensus.

The first-half actual of $2.53 of after-tax RI per share plus a second half carrying the ~$62 million Q3 alternative-credit FRPR crystallisation and ~$32 million of accrued REIT FRPR for potential Q4 recognition underpins the FY2026E figure. The offsetting known negative is the guided ~$10 million of Q3 realized net performance income.

10.5 Embedded expectations

Reverse-engineering $144.02: on a ~21.5x FY2027E after-tax RI multiple with a 3.75% starting yield, the market is paying for roughly 14–17% long-run realized-income compounding — a touch more than the 13–16% implied in June, still below management’s 20%+ near-term target, and far above what a mature fee gatherer (4–6%) would command.

What must be true to justify $144.02: (i) FRE compounds mid-to-high teens, for which the $828 million / 24% contracted embedded fee base plus a record $170 billion of dry powder gets most of the way; (ii) the FRE margin at least holds ~42% and drifts toward 43–44%; (iii) the private-credit default cycle stays concentrated in the small end and does not broaden into Ares’s upper-middle-market book; (iv) the wealth channel continues to grow net of redemptions, as it did in Q2; and (v) no large, equity-funded, full-price acquisition dilutes the perpetual-fee mix.

Is the cycle priced correctly? More correctly than in June. The market has now seen the redemption stress test run and the franchise pass, and has paid for it — but it has paid roughly what the earnings growth was worth, not a premium for the demonstrated durability. That is arguably rational: one quarter of contained redemptions is evidence, not proof, and the asset-side default cycle has not turned.

Three cross-checks triangulate the same place. (a) Reverse-DCF on the dividend. A forward $5.40 growing ~20% for five years then fading to a ~5% terminal rate, discounted at ~9%, lands in the high-$120s to mid-$140s — the current price is fair on the income stream alone. (b) EV to management fees. At 13.4x recurring management fees, Ares pays up for fee quality without absurdity; the metric strips out lumpy carry and rewards precisely the durable base that is the franchise’s strength. © Earnings yield plus growth. A 3.75% dividend plus 16–20% FRE growth is a high-teens total-return algebra if the multiple holds — attractive in absolute terms, entirely contingent on no de-rating from a 77th-percentile start.

10.6 The asymmetry, restated

The payoff remains left-skewed, though less so than in June. Because Ares starts at the 77th percentile of its own valuation history with a 1.566 beta, a credit-cycle disappointment compresses growth and multiple together — the bear zone below captures roughly a 35% drawdown. The upside is more muted: a return to the ~9x price-to-sales of 2024 is not a reasonable base case, so bull upside is driven mostly by earnings compounding into roughly the existing multiple. What has improved is the probability weighting: nine weeks ago the bear case rested on an untested funding shock; today that shock has been run and largely survived, which shifts weight from bear to base without changing the zones much.

10.7 Scenario value zones (not price targets)

At $144.02 the stock sits just above the top of the base zone. Relative to the prior report the zones shift up by roughly $1–2 on higher earnings, while the price has moved up $9.12. In plain terms: the business delivered, and the stock delivered slightly more. (No price target; no recommendation.)

11. Variant Perception

11.1 What consensus believes

Consensus, as expressed in the tape and the sell-side reaction, has moved from “private credit is breaking and Ares is guilty by association” to “the redemption scare was overdone, Ares is a quality compounder, buy the recovery.” Q2 earnings met estimates, analysts raised forecasts, and the stock added 8.2% on 3 August. The published bullish arguments centre on record fundraising, ~90%+ perpetual capital, ~19% AUM CAGR since 2013, and 20%+ expected earnings growth at a low-20s multiple. Consensus is now constructive and, on the evidence, largely correct about the business.

11.2 The strongest bull case

The bull case is that Ares has just demonstrated, in public and under load, that its business model works — and that the market is still pricing it as if the demonstration had not happened. The evidence chain: 94% of fees perpetual or long-dated; a 14.4% redemption request at a single flagship vehicle absorbed as a 0.30%-of-AUM firm-wide quarter with no gate and no forced selling; the redemption queue halving in two quarters; the wealth channel growing through the worst of the shock; institutional demand accelerating because retail withdrew, evidenced by a first-and-final hard-cap close on an $8.5 billion fund; and a record $36 billion raised, $36 billion deployed, $170 billion of dry powder and a record pipeline up 20% sequentially. On top of that sits $828 million of already-contracted embedded fees, 24% of the base, which makes the next two years of mid-to-high-teens FRE growth close to a contractual obligation rather than a forecast. If the industry’s default cycle stays where the data says it is — concentrated in sub-$25 million EBITDA borrowers — Ares’s book (<2% non-accruals, +9% portfolio EBITDA growth) simply does not participate, and the stock compounds earnings into a stable multiple at a high-teens total return.

11.3 The strongest bear case

The bear case has three legs, and the first is new. First, Leonard Green. A stock that trades at 24x fee earnings because those earnings are a perpetual annuity is one signature away from owning $85 billion of episodic closed-end private equity, almost certainly paid for in stock by a company that has never bought a share back, in a segment its own CEO has called non-linear. If that deal signs at a full price, the multiple that justifies today’s price is no longer the right multiple. Second, the margin never comes. At $671 billion of AUM the FRE margin is 42.3%, up 100 basis points in a year, against a peer group in the mid-50s to high-60s; the effective fee rate is falling on liquid-credit mix; platform costs are growing 21% against 13% fee growth; and the CFO has said plainly that margin expansion will be reinvested. If 42% is the structural answer rather than a way-station, Ares is a high-growth, mid-margin fee gatherer being valued as a capital-light compounder. Third, the asset cycle hasn’t turned. Fitch’s record 6.0% default rate is flat, not falling; U.S. direct-lending deal activity fell sharply in Q2 while the industry raised more capital; and $170 billion of dry powder chasing a shrinking deal set is exactly how the next vintage gets underwritten badly. A stock with a 1.566 beta, a -49.7% ten-year maximum drawdown and a 77th-percentile own-history valuation has no cushion for that.

11.4 The genuine variant perception

The market is reading the July–August rally as a verdict on Ares. It is substantially a verdict on the credit-risk factor.

The factor evidence is specific. Ares’s loadings shifted materially since June: market beta rose from +1.24 to +1.46; a DividendYield loading of +0.46 appeared where there was none; the negative Value loading essentially vanished (-0.29 to -0.03); CreditRisk held at +0.31; Momentum is mildly negative at -0.16. Over the trailing 63 trading days the CreditRisk factor returned +5.8% (z +1.0) and DividendYield +6.5% (z +1.1) — the two factors Ares loads most distinctively were the two best-performing style factors of the quarter, alongside SmallSize (+7.6%, z +1.1) and Value (+5.0%, z +1.0). Over 126 days CreditRisk returned +9.8% (z +1.2). The model’s R² is 0.52 with 34.3% annualised idiosyncratic volatility, so this is a “regime plus company” move rather than pure beta — but a material portion of the 17.9% quarterly gain is the market re-embracing credit risk and yield, not re-underwriting Ares.

Three implications follow.

(1) The durability demonstration is under-priced; the recovery is over-attributed. The genuinely new information in Q2 is that a 94%-perpetual fee base absorbed a run at one of its vehicles without breaking. That is a permanent upgrade to the quality of the franchise and it is worth more than 100 basis points of multiple. But the price move that followed was factor-driven and earnings-driven in roughly equal measure, so the specific insight — locked capital works — has not been separately paid for. That is where a patient owner’s edge sits, and it is why “accumulate on weakness” rather than “avoid” is the right posture.

(2) The factor exposure is a two-way street. Ares is now, empirically, a high-beta credit-spread-and-yield vehicle. The same loadings that produced +18% in a quarter when CreditRisk rallied a full standard deviation will produce a symmetric drawdown when credit spreads widen. Consensus is treating the recovery as evidence of safety; the factor model says the stock got more cyclically exposed, not less.

(3) Consensus is offside on where the risk now lives. The published bear case is still about redemptions — an observable, weekly-published, demonstrably improving variable. The actual live risk is a private negotiation with an $85 billion buyout firm that would change what the company is. Almost nobody is underwriting that, because it cannot be modelled. That asymmetry — a well-covered risk improving while an uncovered risk emerges — is the clearest place where the market’s attention is misallocated.

11.5 The 3–5 assumptions that matter most, and what falsifies each

1. The private-credit default cycle stays concentrated in small borrowers. Falsified by: Ares U.S. direct-lending non-accruals rising above ~2.5%, or portfolio-company organic EBITDA growth falling below ~5%.
2. The wealth-channel redemption queue clears. Falsified by: the queue re-expanding above ~$1 billion, or core U.S. individual requests rising back above ~3% of NAV.
3. The FRE margin holds ~42% and drifts up. Falsified by: a full-year outcome below the 0-basis-point floor of guidance, or OMG cost growth continuing to exceed fee growth by 8+ points into 2027.
4. The record dry powder gets deployed at good terms. Falsified by: the pipeline conversion failing — a second consecutive quarter of U.S. direct-lending deployment below ~$10 billion despite a “record” pipeline.
5. No transformational, equity-funded acquisition at a full price. Falsified by: a signed Leonard Green (or comparable) transaction with a majority-stock consideration and no visible multiple discipline.

12. Fact vs. Interpretation

13. Open Questions

1. Does Leonard Green happen, and on what terms? Price, consideration mix (stock versus cash versus earn-out), and whether the perpetual-fee mix is protected. This is now the single largest unknown in the investment case, and it is unobservable until announced.
2. Is 42–44% the structural FRE margin? Management guides to 0–150 basis points a year and says it will reinvest gains. At what AUM, if any, does operating leverage overwhelm platform investment — or is the answer that it never does by design?
3. Does the pipeline convert? NDAs up 35% and logged deals up 30% are precursors, not fees. Two quarters of U.S. direct-lending deployment will settle whether the record pipeline is real conversion or hope.
4. Where does the redemption queue actually land? Management expects “stasis in the next 2 to 3 quarters” and a larger non-traded BDC at year-end 2026 than 2025. Both are falsifiable by year-end.
5. Does the fee-rate mix drag get worse? AUM grew 17% and management fees 13%; liquid credit at sub-0.50% is the stated cause. If the fastest-growing product is the lowest-fee product, AUM growth becomes a progressively worse proxy for revenue.
6. What is the real non-accrual number? Disclosure loosened from specific figures to “less than 2%.” Not evidence of deterioration, but precision matters at this point in a cycle.
7. Does the carry reservoir ever convert? Net accrued carry is flat at ~$1.02 billion over six months, and Q3 realized net performance income is guided to ~$10 million. The carry option keeps not being exercised.
8. Does Ares ever buy back stock? After the October 2027 preferred conversion, with $1.95 billion of TTM FRE and a 3.75% yield, does the permanent-net-issuer posture ever change — or does the DRIP signal the opposite?

14. What Must Be True

Bull case — what must be true:

• FRE compounds mid-to-high teens through 2027, carried by the $828 million / 24% contracted embedded fee base and a record $170 billion of dry powder converting into deployment.
• The FRE margin holds ~42% and drifts to 43–44%, proving the platform build was investment rather than structural cost.
• The default cycle stays concentrated in sub-$25 million EBITDA borrowers; Ares’s U.S. direct-lending non-accruals stay below ~2% and portfolio EBITDA growth stays near high single digits.
• The wealth-channel queue clears and the non-traded BDC ends 2026 larger than it ended 2025, as management expects.
• No transformational acquisition dilutes the 94%-perpetual fee mix that earns the multiple.
• Falsification test (bull): Either (a) two consecutive quarters of sub-12% FRE growth, or (b) U.S. direct-lending non-accruals above ~2.5% with the redemption queue re-expanding past ~$1 billion, or © a signed majority-stock acquisition of a large closed-end private-equity manager at a full price. Any one breaks the “contracted mid-to-high-teens growth in a perpetual-fee annuity” thesis.

Bear case — what must be true:

• The record industry default rate broadens from small borrowers into the upper middle market, impairing deployment, fundraising and marks.
• The sector-low FRE margin proves structural, staying at ~42% or compressing as liquid-credit mix and platform costs grind against fees.
• The multiple de-rates from a 77th-percentile own-history start toward the group trough, compressing growth and multiple together in a 1.566-beta stock with a -49.7% ten-year maximum drawdown.
• The record $170 billion of dry powder gets deployed into a spread-compressed, covenant-light vintage because capital keeps outrunning deal flow.
• Falsification test (bear): Q3’26 through Q1’27 FRE growth tracking ≥18% with U.S. direct-lending non-accruals below 2%, the redemption queue at or near zero, and the FRE margin finishing FY2026 at or above the upper end of the 0–150 basis-point guidance — while no large equity-funded private-equity acquisition is signed. That combination would demonstrate the algorithm holding through the full cycle with the mix intact, and would refute the “rich, high-beta, cyclically-exposed, margin-capped” bear. Note: Q2 2026 delivered the first leg of this test — 20% FRE growth with benign credit metrics — so one of three quarters is already on the board.

15. Source Appendix

See Appendix B below for the full primary-source list. Principal sources: the Form 10-Q for Q2 2026 (filed 2026-08-07), the Q2 2026 earnings release and presentation (8-K, 2026-07-31), the Q2 2026 earnings-call transcript (2026-07-31), the Q1 2026 / Q4 2025 / Q3 2025 earnings releases, the credit-facility amendment 8-K (2026-05-28), the Form 4 insider corpus (2026-06-01 to 2026-08-03), ROIC.ai fundamentals and valuation data, the AZI valuation-percentile index and price history, the FactorsToday factor model, and my 14 June 2026 report on Ares.

The analytical body of this article is deliberately position-free and carries no recommendation and no price target; the sole exception is the labeled opinion block at the top, which is my own subjective view. This article is general information and commentary, not investment advice.

APPENDIX A — Standard Diligence Questionnaire

Ares Management Corporation (NYSE: ARES) — supplemental to the article above. Report date 2026-08-15; an update to the 14 June 2026 edition. Fact / Interpretation / Assumption labeled where it matters. Where a question does not map to an alternative-asset-manager model, the correct sector analog is given. Where the answer has changed since the prior report, that is flagged.

General

What thoughtful questions have other investors asked about this company?

The debate list has rotated meaningfully in nine weeks. The four questions now being asked, in order of how much they move the stock:

1. “Will Ares buy Leonard Green, and what does that do to the multiple?” — New since June. The FT reported preliminary talks on 28 July 2026 to acquire an ~$85 billion buyout firm, which would take Ares’s private-equity AUM from ~$25 billion to over $100 billion. On the 31 July call Alex Blostein of Goldman Sachs put it first and directly. The sub-question that matters is consideration mix: a permanent net issuer with no buyback history buying a large closed-end PE manager would be paying in the currency the market values most highly for the asset class it values least.
2. “Was the redemption wave the end of something or the start?” — Asked in four different forms on the Q2 call. The answer management gave is unusually specific and is the most quantified disclosure any large manager has given on this: ~95% of accounts stayed; core U.S. individual requests were ~2.5% of NAV and fell ~35% sequentially; the top ten redeemers were about half of all requests; the regional queue halved from ~$1.2 billion to a little over $600 million; and management expects “stasis in the next 2 to 3 quarters.”
3. “Is the sector-low FRE margin structural or a coiled spring?” — Unchanged from June, and Bill Katz of TD Cowen asked it directly. The answer is now partially available: 42.3% year to date, ~100 basis points of improvement, guidance of 0–150 basis points, and a CFO who says explicitly that margin gains will be reinvested into origination and distribution capacity.
4. “How should one value it?” — GAAP is unusable (a screen P/E of 45–82x, a negative price-to-tangible-book, and a $44 billion screen enterprise value that wrongly includes ~$9.5 billion of non-recourse fund debt and ~$4.6 billion of non-controlling interests). The live debate is price-to-FRE versus price-to-after-tax-realized-income, and what multiple a credit-heavy, low-carry manager deserves relative to KKR and Blackstone.

A fifth question — the one nobody is asking loudly enough — is whether the fee rate is falling as fast as fee-paying AUM is rising. The Q2 10-Q states that the Credit Group’s effective management fee rate declined “primarily attributable to increases in FPAUM from funds in our liquid credit strategy, which have an effective fee rate of less than 0.50%.” AUM grew 17.3% and management fees grew 13%. That four-point wedge is the quietest structural issue in the business.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low?

Interpretation: Split, and the split is the point. Fee-related earnings are at a structural high and rising — $1.95 billion trailing twelve months, +20% in the quarter — but they are recurring and contractual rather than cyclical-peak: 94% of management fees come from perpetual or long-dated capital. The cyclical layer is at a low. Realized net performance income was only ~$51 million in Q2, and management guided Q3 to approximately $10 million; the net carry reservoir (accrued carried interest of $4,141 million less performance-related compensation payable of $3,123 million) is flat at ~$1.02 billion over six months. Deployment was depressed for four quarters and is only now inflecting. So: durable earnings high and compounding, cyclical earnings depressed. That configuration is favourable — the growth you are paying for is the kind that does not need the cycle.

Driven by the external environment or internal actions?

Both, and empirically the external component is larger than the narrative suggests. Internal: fundraising execution (record $36 billion quarter), product architecture (eight wealth products, so the channel grew while private credit specifically was in outflow), the GCP integration, the Ada digital-infrastructure build. External: credit spreads, M&A volumes, rates and risk appetite. The factor model is blunt about the balance — Ares carries a market beta of 1.566, a CreditRisk loading of +0.31 and a DividendYield loading of +0.46, with a model R² of 0.52. Roughly half the variance in the stock is factor-explained.

How stable are revenues?

Very, by industry standards, and more stable than at the prior report: 94% of Q2 2026 management fees came from perpetual capital or long-dated funds (up from 93% in FY2025), and 84% of AUM sits in those vehicles. (Fact, Q2’26 10-Q.) The 2026 stress episode is the empirical proof: a 14.4% redemption request at a $23 billion flagship vehicle produced firm-wide redemptions of $2.03 billion, 0.30% of AUM, against $36 billion of gross inflows in the same quarter.

Outlook for products/services?

Multiple credible legs, several with dated milestones: the next-generation U.S. senior direct-lending commingled fund and a new Evergreen core product (first closes expected autumn 2026); the seventh European direct-lending fund (early 2027); infrastructure debt fund six (~$3.7 billion raised, final close expected above the prior $5 billion vintage); the fifth Japan industrial development fund (final close at hard cap in Q3, above the prior $2.5 billion vintage); the global digital-infrastructure fund (closings late Q3 into Q4, completion 2027); a real-estate secondaries fund (initial close in 2H); and interval-fund structures for the mass-affluent and model-portfolio markets.

How big will this market be — growing, shrinking, domestic or international?

Growing, and international. Global private credit is ~$1.7 trillion with sell-side projections above $2.6 trillion by 2029. Ares is genuinely global (U.S., Europe, APAC, Middle East, South America), and management describes European direct lending as the current bright spot precisely because it is more fragmented, with fewer scaled lenders. Adjacent markets are large: Ares sizes the third-party data-centre market at ~$900 billion; credit-secondaries industry volumes in the first six months of 2026 already matched full-year 2025. The near-term cycle, not the market size, is the risk.

Business Quality & Competitive Moat

Is the industry getting more or less competitive?

Bifurcating, and the direction favours Ares. Competition for assets remains intense — the effective fee rate is falling on liquid-credit mix, and U.S. direct-lending activity fell sharply in Q2 while industry fundraising rebounded, which is the classic precondition for spread compression. But competition for capital is consolidating toward scale leaders, and the 2026 shock accelerated that: Arougheti’s stated read is that “our competitive advantage is improving as some of the retail-heavy competitors are not forming capital to the same extent that we are.” Ares raised a record $36 billion in the quarter that its retail-dependent competitors spent managing redemptions.

How profitable is the business (ROIC, ROE)?

GAAP returns are meaningless here — the Up-C structure and fund consolidation produce a negative tangible book value and a GAAP ROIC in the low single digits. The correct sector analogs are fee-related earnings against corporate capital employed and after-tax realized income per share. On that basis: TTM FRE $1,954.4 million against $4,577 million of corporate debt and modest equity capital; TTM after-tax realized income $1,874.9 million, $5.17 per share. The business is highly profitable and structurally capital-light. Use FRE and RI; never GAAP returns.

How profitable is the industry — competitors, barriers to entry?

A high-margin oligopoly with a long tail. Barriers are scale, track record, distribution and locked capital — all four of which compound. Ares is #1 in direct lending; peers are Blackstone, Apollo, KKR, Brookfield, Carlyle, Blue Owl and TPG. The margin spread within the group is wide and Ares sits at the bottom: 42.3% FRE margin versus a peer group in the mid-50s to high-60s.

Can the business be easily understood?

Moderately. The model — fees on AUM — is simple. The reporting is not: GAAP consolidation, the FRE / RI / FRPR / Part I fee vocabulary, five investment groups plus an Operations Management Group cost centre, and a share count spread across Class A, non-voting, Class C/AOG units and a mandatory convertible preferred. The opacity is itself a mild negative — it is why screen-based valuation of this stock is systematically wrong, and why a naive investor cannot easily check management’s arithmetic.

Can it be undermined by foreign low-cost labor?

No. This is a relationship, judgment and capital business, not a cost-arbitrage one. The relevant technology question is different and management addressed it: Ares is deploying “productivity AI” across repeatable functions (RFPs, DDQs, AML, KYC, legal document comparison) and building applied-AI frameworks on its proprietary deal data — including data on deals it declined. Interpretation: this is a plausible medium-term margin lever, and it is one of the few credible paths from 42% to a materially higher FRE margin.

Do brands matter?

Yes, and the brand is the track record. “Ares” and “ARCC” are institutional brands; ARCC’s twenty-one-year publicly auditable record is the fundraising calling card. The 2026 episode enhanced the brand: Ares capped redemptions at the contractual 5% without gating or force-selling, at the same moment a peer gated a fund and force-sold ~$1.4 billion of loans.

Nature of competition?

Competition for limited-partner capital and for deals, won on scale, track record, certainty of capital and platform breadth. The Q2 evidence for the “certainty of capital” advantage is Pathfinder III: an $8.5 billion first-and-final close at a raised hard cap against a $6.5 billion target, with demand well in excess — a fundraise Arougheti said he could not recall Ares ever doing before.

Customers’ switching costs?

Real but moderate, and now empirically measured. Capital is contractually locked (multi-year or perpetual), but limited partners can decline the next vintage and semi-liquid retail holders can request redemption quarterly. The 2026 test put a number on it: when a redemption window opened under maximum stress, ~95% of accounts in the flagship non-traded BDC stayed. Management is now hardening the perimeter with “lockups and redemption penalties and regional redemption queues” on new share classes.

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet?

Three, and they are large. (1) The embedded fee-earning power of undeployed capital: $114 billion of AUM not yet paying fees, of which $92.6 billion is available for deployment and $4.1 billion is development assets, together capable of generating ~$828.2 million of incremental annual management fees — 24% of the trailing base-fee run-rate. That is a contractual economic asset carried nowhere on the balance sheet. (2) The net carry reservoir: accrued carried interest of $4,141 million less performance-related compensation payable of $3,123 million, a net ~$1.02 billion. (3) Indefinite-lived management contracts, including certain BlueCove contracts not subject to amortisation.

Off-balance-sheet liabilities?

Fund commitments and guarantees exist but are modest relative to the firm. The larger and more important nuance runs the other way: $6,952 million of CLO loan obligations and $2,531 million of Consolidated Fund borrowings sit on the balance sheet but are non-recourse to Ares. Any screen that adds them to enterprise value — as ROIC.ai’s $44.2 billion figure does — overstates the claim on shareholders by roughly $9.5 billion.

How conservative is the accounting?

GAAP is conservative but opaque (heavy consolidation, large non-controlling interests). The non-GAAP measures are the industry standard and are the right basis for valuation, but they are not neutral: FRE and RI add back $182.8 million of equity compensation in the quarter and $386.4 million year to date, plus $28.2 million of acquisition-related compensation. That is a real cost, borne through the 1.0% share-count growth of the last two quarters, and it is the single largest quality-of-earnings caveat.

One item to normalise out of GAAP: the $37.3 million bargain purchase gain on BlueCove, recorded in other income for the six months. It is a favourable signal about the price paid — Ares acquired net assets for less than their appraised fair value — but it is not recurring earnings.

How CapEx-hungry is the business?

Very low. Investing cash outflows are furniture, equipment and leasehold improvements (notably the New York headquarters expansion) against $1.0 billion of first-half realized income. Growth capital goes into fund co-investments and acquisitions, not physical assets. Note the one nuance introduced by the Ada platform: Ares runs a vertically integrated data-centre development team of 100+ professionals, but charges that team’s cost back to the fund, so the capital and cost intensity sits with limited partners, not the manager — an explicitly better economic arrangement than the outsourced peer model.

Capital Allocation & Management

How much FCF does the business generate, how does management use it, and what is the philosophy?

The correct sector analog for free cash flow is after-tax realized income: $1,874.9 million trailing twelve months. Uses, in order: the dividend ($610.8 million paid on common in the first half), fund co-investment, and acquisitions. The philosophy is explicit — the dividend is anchored to after-tax fee-related earnings, not GAAP, which is why it is comfortably covered by recurring fees rather than lumpy carry, and why it has grown ~20% a year.

Significant acquisitions recently?

Yes, and the pace is quickening. BlueCove (closed 1 February 2026) — a London systematic fixed-income manager, acquired at a $37.3 million bargain purchase gain, contributing $5.6 million of Credit fees in the quarter. GCP International (closed 1 March 2025, ~$3.9 billion initial, up to ~$5.6 billion with earn-outs) — management now expects the earn-out to be paid, and makes the correct point that milestone-based earn-outs “effectively… buy down our multiple.” Prior: Landmark (2021), Black Creek (2021), AMP infrastructure debt (2022), Crescent Point (2024).

And the one that has not happened: the FT reported on 28 July 2026 that Ares held preliminary talks to acquire Leonard Green & Partners (~$85 billion AUM). Interpretation: this would be roughly 3.4x the size of GCP by AUM and the largest transaction in the firm’s history, into the segment with the least durable economics. It is the single largest open variable in the investment case.

Separately, and importantly: the $1.7 billion Whitestone REIT acquisition completed 14 July 2026 was made by Ares Real Estate funds, not by Ares Management. It consumes limited-partner capital and generates fees for Ares. It must not be read as a corporate capital-allocation decision.

Buying back shares?

No. Ares has never repurchased stock and remains a permanent net issuer. Fully-exchanged shares rose from ~327.1 million to 330.28 million in two quarters (+1.0%). The $1.46 billion Series B mandatory convertible preferred converts on 1 October 2027, adding roughly 30 million shares. A new Dividend Reinvestment Program becomes effective with the September 2026 dividend — a further, mild, ongoing source of issuance.

Issuing large amounts of new shares to insiders?

Equity compensation of $386.4 million in the first half ($182.8 million in Q2) is material and is added back to reach FRE and RI. This is the biggest quality-of-earnings caveat in the business and is unchanged in character from the prior report.

Compensation policy of directors/management?

Fact (proxy): the founders — Arougheti and deVeer — take no salary and no cash bonus, and are paid through carried interest and equity, aligning them with fund limited partners rather than with reported earnings. Non-founder named executives receive salary plus bonus. Carry vests over five years with clawback. Say-on-pay support was 92.3%. Non-employee directors receive an annual equity retainer (1,728 shares each on 30 July 2026).

Motivations of management?

Strongly ownership-aligned: co-founder Ressler holds ~19.7% fully exchanged, and the founders’ wealth is in the stock and in fund carry rather than in cash compensation. The governance trade-off is founder-controlled voting.

One change worth flagging. Between 1 June and 3 August 2026 the Form 4 record contains no open-market purchase by any insider — only routine director equity retainers (code A at $0), tax withholding on vesting (code F, including 82,957 shares each for Arougheti and deVeer at $111.31 on 30 June), and one gift. Nobody bought the 29 June close of $107.60. A director had bought 10,000 shares at $126.61 on 6 February. Interpretation: not evidence of anything wrong — blackout windows and concentration constraints are real — but the prior report cited the February purchase as part of its alignment case, and the signal was not repeated at a materially better price.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer?

No. Ares is a C-corporation issuing a Form 1099, not a K-1 — unlike legacy alternative-manager partnership structures. This broadens the investor base (index- and 40-Act-eligible; the company was added to the S&P 500 in December 2025) and is a structural positive.

Dividend policy?

A variable dividend set against after-tax fee-related earnings, not GAAP. Currently $1.35 per quarter, held for a third consecutive quarter (declared 31 July 2026, payable 30 September), +20% versus the year-ago quarter; $5.40 annualised for a 3.75% forward yield at $144.02. The annual step-up has historically arrived with the Q4 print. Long-term guidance is ~20% dividend growth. Payout in the first half was $610.8 million against $955.5 million of FRE — comfortably covered by recurring fees.

How profitable is the business?

Highly, on the relevant measures: 42.3% FRE margin, $1.95 billion of TTM fee-related earnings on a capital-light base. The FRE margin is the one place where Ares is demonstrably second-tier among the majors, and management has said it will reinvest margin gains rather than bank them.

Is net income diverging from cash from operations?

On GAAP, yes and permanently — consolidation noise means GAAP net income attributable to Ares of $150.6 million in the quarter bears no relation to the $521.5 million of realized income the business actually generated. On the relevant basis, conversion is healthy: FRE of $955.5 million and RI of $1,024.2 million in the first half comfortably funded $610.8 million of common dividends. The divergence is an accounting artifact, not a red flag — but it is the reason screen-based analysis of this stock fails.

Risks & Downside

What factors would cause the stock to decline?

In order of how much they would matter: (1) a large, equity-funded, full-price private-equity acquisition diluting the 94%-perpetual fee mix that earns the multiple; (2) a broadening of the default cycle from small borrowers into the upper middle market, visible first in U.S. direct-lending non-accruals rising above ~2.5%; (3) a multiple de-rating from a 77th-percentile own-history starting point in a stock with a 1.566 beta; (4) the FRE margin failing to inflect; (5) renewed wealth-channel redemptions; (6) a general risk-off move, given that Ares now loads +0.31 to CreditRisk and +0.46 to DividendYield and those factors cut both ways.

Risk of a catastrophic loss?

Low. The business is capital-light with an investment-grade corporate balance sheet at 2.34x TTM FRE; the $9.5 billion of CLO and fund debt on the balance sheet is non-recourse; there is no owned-insurance spread risk (the insurance model is asset-light, managing rather than owning balance sheets); and the fee base is contractually locked and diversified across five investment groups. The realistic downside is cyclical — a 30–50% drawdown, which the ten-year record (-49.7% maximum drawdown) says is characteristic rather than exceptional for this name.

Chance of a total loss?

Very low. Nothing in the evidence base points toward insolvency. The non-recourse structure of fund and CLO debt insulates the parent, and corporate leverage at 2.34x fee-related earnings is conservative for an annuity-like fee stream.

Recent News & Events

Has the business environment changed recently?

Yes, twice, in opposite directions. The retail funding environment improved. After the June escalation — a 14.4% redemption request at the ~$23 billion flagship non-traded BDC, the 5% cap re-imposed on 25 June, and a 20.5% nine-session decline in the stock to $107.60 — the queue halved to ~$600 million, core U.S. requests fell ~35% sequentially, and Bank of America’s published view is that BDC redemption requests likely peaked in Q2 2026. Every major non-traded BDC hit the 5% cap that quarter, so this was industry-wide rather than Ares-specific. The asset environment did not improve. Fitch’s U.S. private-credit default rate reached a record 6.0% in April 2026 and was still 6.0% in May; U.S. direct-lending deal activity fell sharply in Q2 even as fundraising rebounded; and on 22 June the Bank of England launched its first private-markets stress test with Ares among five participants.

Significant acquisitions?

BlueCove closed 1 February 2026 (with a $37.3 million bargain purchase gain). Whitestone REIT closed 14 July 2026 at ~$1.7 billion — at the fund level. And the Leonard Green talks were reported 28 July 2026, unconfirmed and preliminary.

Change in accounting policies?

None new this period. The Q1 2025 segment realignment (real estate and infrastructure combined into a Real Assets Group; interest-expense allocation changed) still impairs comparability across that boundary. The GCP acquisition contributed four months in the six months ended 30 June 2025 versus six months in 2026, which management explicitly flags as a comparability limitation on the year-to-date numbers.

Recent changes — new markets, facilities, management?

Brent Canada was appointed Head of Ares Infrastructure Debt on 18 June 2026, succeeding Patrick Trears. The New York headquarters is being expanded. The credit facility was amended in May 2026 — commitments raised from $1.84 billion to $2.50 billion (accordion to $3.0 billion), maturity extended to May 2031 — and a new $400 million term loan due 2029 was added, taking corporate debt from $3.94 billion to $4.58 billion in six months. The $450 million of subordinated notes reset from 4.125% to 7.357% on 30 June 2026. A Dividend Reinvestment Program becomes effective with the September 2026 dividend. New product architecture is underway in the wealth channel: interval funds for the mass-affluent and model-portfolio markets, and new share classes with lockups, redemption penalties and regional redemption queues.

APPENDIX B — Source Appendix

Ares Management Corporation (NYSE: ARES). Report date 2026-08-15 — an update to the 14 June 2026 report. Public sources only, primary sources first. CIK 0001176948. SEC filings accessed via EDGAR; ROIC.ai, AZI and FactorsToday accessed 2026-08-15.

Primary — SEC filings (EDGAR, CIK 0001176948)

1. Form 10-Q, Q2 2026 — filed 2026-08-07, period ended 2026-06-30. The central document of this update. Used for: AUM and FPAUM rollforwards including the redemptions line ($2,027M in Q2’26 vs $1,122M in Q2’25); segment FRE and management-fee decomposition; the FRE/RI-to-GAAP reconciliation; the 94%-of-fees perpetual/long-dated disclosure; the $828.2M / 24% embedded-fee disclosure; the $114B of AUM not yet paying fees and $170B of available capital; Note 3 (BlueCove acquisition and the $37.3M bargain purchase gain); Note 6 (debt schedule, revolver amendment, subordinated-note reset to 7.357%); the balance sheet (Company cash $557.1M; accrued carried interest $4,141.1M; performance-related compensation payable $3,122.6M; CLO loan obligations $6,951.7M and fund borrowings $2,531.2M, both non-recourse); and the cover-page share counts (Class A 223,957,742; non-voting 3,489,911; Class C 102,828,576; Series B preferred 30,000,000, as of 2026-08-03). https://www.sec.gov/Archives/edgar/data/1176948/000162828026054538/ares-20260630.htm
2. Form 8-K, 2026-07-31 (Item 2.02) with EX-99.1 earnings release and EX-99.2 earnings presentation — Q2 2026 results: GAAP net income attributable to Ares $150.6M ($0.49/sh); after-tax realized income $467.6M ($1.29/sh); FRE $491.1M; AUM over $671B; record $36B of inflows; record $170B of dry powder; $1.35 common dividend declared (payable 2026-09-30); $0.84375 preferred dividend; Dividend Reinvestment Program effective with the September dividend. https://www.sec.gov/Archives/edgar/data/1176948/000162828026051191/a2026q2-ex991.htm
3. Form 8-K, 2026-05-28 (event 2026-05-21; Items 1.01 / 2.03) — Amendment No. 14 to the Sixth Amended and Restated Credit Agreement: revolver commitments raised from $1.84B (with a $660M accordion) to $2.50B (with a $500M accordion, $3.0B total facility); maturity extended from 2030-04-22 to 2031-05-21; Term SOFR credit-spread adjustment removed. Agent: JPMorgan Chase Bank, N.A. https://www.sec.gov/Archives/edgar/data/1176948/000162828026038606/ares-20260521.htm
4. Form 8-K, 2026-06-11 (event 2026-06-08; Item 5.07) — annual meeting voting results. https://www.sec.gov/Archives/edgar/data/1176948/000162828026042576/ares-20260608.htm
5. Form 8-K, 2026-07-10 — earnings-call time change (Items 2.02 / 7.01).
6. Prior-quarter earnings releases (used to build the trailing-twelve-month series): Q1 2026 8-K 2026-05-01, EX-99.1 — after-tax RI $452.4M, $1.24/sh; FRE $464.4M; record Q1 fundraising $30B. Q4/FY2025 8-K 2026-02-05, EX-99.1 — after-tax RI $529.1M, $1.45/sh; FRE $527.7M. Q3 2025 8-K 2025-11-03, EX-99.1 — after-tax RI $425.8M, $1.19/sh; FRE $471.2M.
7. Form 4 insider filings, 2026-06-01 to 2026-08-03 (ten filings, raw XML parsed for transaction codes) — 2026-07-30 annual director equity retainers of 1,728 shares each (code A, $0) to Lynton, Olian, Joubert, Naughton, Bhutani and Bush; 2026-07-01 CFO Phillips 2,583 shares withheld for taxes (code F, $113.63); 2026-06-30 CEO Arougheti and Co-President deVeer 82,957 shares each withheld for taxes (code F, $111.31); 2026-06-03 Co-President Jacobson 8,000-share gift (code G). No open-market purchases (code P) in the period.
8. Schedule 13G / 13G-A filings, 2026-05-14, 2026-05-15, 2026-08-12 and 2026-08-13 (four) — routine institutional ownership updates; no control implication.
9. Carried-forward primary sources from the 2026-06-14 report (baseline, not re-fetched this run): Form 10-K FY2025 (filed 2026-02-25); Forms 10-K FY2021–FY2024; DEF 14A proxy (filed 2026-04-21); FY2025 Annual Report; Series B mandatory convertible preferred and senior-note capital-structure filings.

Primary — Earnings-call transcript

10. Q2 2026 earnings call, 2026-07-31 (Michael Arougheti, CEO; Jarrod Phillips, CFO; Blair Jacobson, Co-President; Greg Mason, IR). The richest single source in this update. Used for: the 42.3% year-to-date FRE margin and 0–150bps guidance; the 84%-of-AUM / 94%-of-fees perpetual-capital split; Part I fees ~$154M (+20%); FRPR ~$41M (+143%) and Q3/Q4 FRPR guidance (~$62M and ~$32M); Q3 realized net performance income guidance of ~$10M; the 13.7% tax rate; U.S. direct-lending non-accruals “less than 2%” and portfolio EBITDA +9%; ASIF non-accruals ~0.5% and EBITDA +13%; the full redemption quantification (~95% retention, core U.S. requests ~2.5% of NAV down ~35% QoQ, top-10 redeemers ~half of requests, queue $1.2B → ~$600M, “stasis in the next 2 to 3 quarters,” BDC expected larger at YE26 than YE25); wealth-channel detail (>$76B AUM, $3.9B Q2 gross equity, ~$1.5B in July, Stanger #2 rank, Evergreen core infrastructure $5.7B); deployment ($36B vs $27B, U.S. DL $12.4B with 75% incumbent, record pipeline +20% QoQ, NDAs +35%); Ada digital infrastructure (7 campuses, 22 investments, ~1GW, 700MW seed pipeline, $50–100M FRE in 2027+); ABF consumer exposure (<5% consumer, <1% subprime, <1% auto); Pathfinder III first-and-final at an $8.5B hard cap; the GCP earn-out commentary; and the private-equity M&A framework exchange with Alex Blostein (“I think the answer is probably”; “the price has to be right”). Publicly available via the company’s investor-relations site and public transcript services.

11. Q1 2026 and Q4 2025 earnings calls — carried forward from the prior report as baseline context (multi-year targets of 16–20% FRE / 20%+ RI / ~20% dividend growth; the 20% dividend increase to $1.35).

Quantitative data sources

12. ROIC.ai (accessed 2026-08-15, identifier NYSE:ARES) — enterprise-value and valuation-multiple series (quarterly, four periods; annual, twelve periods). Used to establish the own-history price-to-sales range (FY2019 2.18x, FY2021 3.16x, FY2022 3.93x, FY2023 6.04x, FY2024 9.03x, FY2025 6.27x) and to document — and then discard — the screen artifacts: Q2’26 market cap $25.1B (Class A only), enterprise value $44.2B (includes ~$9.5B of non-recourse fund debt and ~$4.6B of non-controlling interests), FY2025 P/E 82.4x and price-to-tangible-book -13.0x. Third-party aggregated data; reconciled to the filings, which govern.
13. ROIC.ai company news feed (accessed 2026-08-15, window from 2026-06-01) — used as the triage layer for the recent-events timeline. Material items surfaced and then verified against their underlying sources: the 25 June redemption-cap reports, the 9 July Reuters direct-lending piece, the 10 June Pathfinder III close, the 14 July Whitestone completion, the 22 June BoE stress test, the 18 June Infrastructure Debt leadership change, the 31 July Q2 results and the 3 August estimate raises.
14. AZI valuation_index own-history percentiles (2026-08-14 data) — ARES: composite 68.7; P/S 5.26x at the 77.1st percentile; P/B 8.02x at the 72.4th; P/E 44.8x at the 56.6th; price $144.02. Compared with the prior report’s 2026-06-12 readings (composite 66.3; P/S percentile 77.1; P/B 60.7; P/E 61.2). Cohort readings on the same date: BAM 85.1, APO 84.2, KKR 74.1, BX 71.7, CG 70.5, ARES 68.7, OWL 43.0, TPG 40.2, HLNE 27.6. These are own-history percentiles only and are never used cross-sectionally as cheapness measures. The P/E percentile is discounted throughout because GAAP EPS is distorted by the Up-C and consolidation structure; P/S is treated as the cleanest own-history gauge.
15. AZI daily price history (https://azitrading.com/controls/download-data.php?t=ARES, pulled 2026-08-15) — adjusted and unadjusted OHLCV with dividend and split columns and 21/50/200-day EMAs. Source for the five-year event map: all-time and five-year high $198.22 (2025-01-31); 52-week high $189.27 (2025-08-18); 2026 low $96.50 (2026-03-12); the June leg down $135.36 (6/15) → $107.60 (6/29), -20.5%; the recovery to $144.02 (2026-08-14), +33.8%; period anchors for 2021–2025; and the largest single-day moves (-11.2% on 2026-02-05; +8.2% on 2026-08-03). Note the dividend adjustment: the 2026-06-12 close reads $134.90 unadjusted and $133.55 adjusted after the 2026-06-16 $1.35 ex-dividend; unadjusted closes are used throughout the event map for comparability with the prior report.
16. FactorsToday factor model (https://www.factorstoday.com/api, all series pulled 2026-08-15) —
    • /api/stock-loadings/ARES (Base + Sector model, 2026-08-14, R² 0.489): Market +1.464, Sector: Financials +0.759, DividendYield +0.464, LowVolatility -0.335, CreditRisk +0.310, BetaFactor +0.250, SmallSize +0.240, Momentum -0.156, Value -0.032. (Read within a single model only; betas legitimately differ across the nested models because each re-strips the factor hierarchy.)
    • /api/leaderboard/ARES: 10-year +28.8% annualised, Sharpe 0.73, Sortino 0.98, volatility 36.6%, max drawdown -49.7%; 5-year +18.3%; 3-year +16.0%; 1-year -21.3% (Sharpe -0.53, max DD -48.4%); 6-month +21.1% annualised; 3-month +93.0% annualised. All horizons are annualised: the 3-month figure de-annualises to roughly +17.9% for the quarter.
    • /api/stock-info/ARES: beta 1.566, alpha -0.154, rs_6m +7.33, rs_12m -21.41, rs_peak -23.18, trailing dividend yield 4.02%, market cap $49.3B (all-unit basis).
    • /api/stock-specific-vol/ARES: idiosyncratic volatility 34.3% annualised, R² 0.519.
    • /api/related-stocks/ARES: TPG 0.969, OWL 0.959, KKR 0.951, APO 0.939, HLNE 0.935, BX 0.923, BAM 0.920.
    • /api/factor-returns/historic: trailing-63-day factor returns CreditRisk +5.8% (z +1.0), DividendYield +6.5% (z +1.1), SmallSize +7.6% (z +1.1), Value +5.0% (z +1.0), Market +4.1% (z +0.2), Momentum +1.2% (z -0.2), BetaFactor -3.5% (z -0.5); trailing-126-day CreditRisk +9.8% (z +1.2). Third-party statistical estimates. Loadings, returns and drawdowns are reportable facts; any statement that a pattern will continue or revert is labelled interpretation and regime-caveated.
17. SEC EDGAR full-text filing index for CIK 0001176948 — the filing enumeration underlying the SEC review above.

External / industry sources

18. Reuters, “Ares caps withdrawals again at flagship $23 billion private credit fund,” 2026-06-25.
19. Barron’s, “Ares Caps Private-Credit Fund Redemptions Again as 14% Seek Exits,” 2026-06-25 — the 14.4% redemption-request figure and the year-end backlog-clearing expectation.
20. Reuters, “US direct-lending activity falls even as private credit firms raise more cash,” 2026-07-09 — the deployment-versus-fundraising divergence.
21. Reuters, “Ares hauls record $36 billion on private credit fundraising momentum,” 2026-07-31.
22. Reuters, “Most withdrawals from Ares private credit fund came from outside US, CEO says,” 2026-06-10.
23. Financial Times, reported via Private Equity Wire (“Ares weighs acquisition of buyout firm Leonard Green,” 2026-07-28) and Axios (2026-07-28) — preliminary talks to acquire Leonard Green & Partners (~$85B AUM); Ares PE from ~$25B to over $100B; negotiations preliminary and may not lead to an agreement; no valuation disclosed. Not confirmed by the company.
24. Fitch Ratings (via published commentary, e.g. Funds Society) — U.S. private-credit default rate at a record 6.0% in April 2026, unchanged at 6.0% in May 2026; 2025 private-credit-backed borrower default rate 9.2%; size stratification: 15.8% for sub-$25M EBITDA borrowers versus 4.0% for borrowers above $100M EBITDA in 2025.
25. PitchBook, “Private credit BDC redemption requests likely to peak in Q2 2026 – BofA.”
26. Investing.com / Reuters, “Blue Owl keeps 5% redemption caps as OCIC requests ease from prior quarter” — OCIC requests $3.6B in Q2 versus $4.2B in Q1; Apollo, Ares, Morgan Stanley, HPS, Cliffwater, Monroe and Blackstone all repurchased at the 5% cap in Q2; ~$12.9B withdrawn from wealth-channel private-credit funds in the first five months of 2026.
27. Zacks, “BoE Unveils Private Market Stress Test to Assess Systemic Risks,” 2026-06-22 — Apollo, Ares, Blackstone, KKR and JPMorgan participating in the Bank of England’s first private-markets stress test.
28. Business Wire, “Ares Completes Acquisition of Whitestone REIT,” 2026-07-14 — $19.00 per share, ~$1.7B all-cash, 54 properties, by “certain Ares Real Estate funds” (fund-level, not corporate).
29. Business Wire, “Ares Raises $12.7 Billion to Invest in Asset-Based Finance Through the Pathfinder Closed-End Strategy,” 2026-06-10 — Pathfinder III final close at $8.5B of LP commitments, oversubscribed at a raised hard cap against a $6.5B target and a $6.6B 2023-vintage predecessor.
30. Business Wire, “Ares Appoints Brent Canada as Head of Infrastructure Debt,” 2026-06-18 — succeeding Patrick Trears.
31. PR Newswire, “Ares Management Announces Second Quarter 2026 U.S. Direct Lending Origination Activity,” 2026-07-31 — ~$8.2B closed across 69 transactions in Q2; ~$52.3B across 347 transactions in the twelve months to 30 June 2026.
32. PR Newswire, “Ares Capital Corporation Announces June 30, 2026 Financial Results and Declares Third Quarter 2026 Dividend of $0.48 Per Share,” 2026-07-29.
33. Benzinga, “Ares Management Analysts Raise Their Forecasts After Q2 Earnings,” 2026-08-03; Zacks, “Ares Management Q2 Earnings Meet Estimates, AUM Rises Y/Y,” 2026-07-31 — used only to characterise the sell-side reaction that coincided with the 3 August +8.2% move. No analyst target is used as, or converted into, a price target.
34. Industry context carried forward from the 2026-06-14 report (not re-verified this run): global private-credit market sizing (~$1.7T, projected $2.6T+ by 2029); Executive Order 14330 (August 2025) and the DOL/EBSA proposed safe-harbour rule (March 2026) on defined-contribution access to private assets; top-10 funds capturing ~46% of 2025 commitments.

Prior work by the author

35. “Ares Management Corporation (NYSE: ARES) — The Best House on the Private-Credit Block, Still Not on Sale,” 14 June 2026 — my prior article on the company, used as the baseline for this update: the durable scaffolding (industry structure, moat mechanism, GAAP-distortion handling, segment architecture), the prior verdict (HOLD / accumulate below ~$115; fair-value zone ~$126–140; conviction medium), and the falsification tests re-run in this article.
36. Prior articles on same-sector peers (Blue Owl, KKR, Apollo, Blackstone, Carlyle and TPG, all published June 2026) — used as June-2026-vintage peer context only, and explicitly labelled as such in the text. The absolute peer fee-earnings-multiple comparison from those pieces was not rebuilt from fresh peer filings for this update; the fresh peer evidence used here is the 2026-08-14 own-history percentile set (item 14).

Management commentary from the transcript and IR materials is treated as hypothesis and validated against filings, financial statements and external data, per the research framework. Where management commentary and external evidence diverge — notably management’s “no signs of a turn in the credit cycle” against Fitch’s record 6.0% industry default rate — both are presented and the reconciliation (borrower-size stratification) is stated as interpretation. No figure from any third-party aggregator, and no sell-side estimate or target, is used as or converted into a price target. Nothing in this report states, implies or assumes any position in the security.